[CTL precursor-oriented peptide vaccine therapy for malignant glioma].
Yajima
Naoki
N
Department of Neurosurgery, Brain Research Institue, Niigata University.
Yamanaka
Ryuya
R
Tanaka
Ryuichi
R
Shigemori
Minoru
M
Mine
Takashi
T
Itoh
Kyougo
K
D001932:Brain Neoplasms / Q000628:therapy*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D018984:Epitopes, T-Lymphocyte; D005910:Glioma / Q000628:therapy*; D006680:HLA Antigens; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008562:Membrane Glycoproteins / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D022223:Vaccines, Subunit / Q000627:therapeutic use
D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte; D006680:HLA Antigens; D008562:Membrane Glycoproteins; D022223:Vaccines, Subunit; C053387:endoplasmin